Hi all
Re the BARDA "Revenue" discussion. As far as I understood it BARDA reimburses us for expenses incurred. While that revenue (hence also costs) grosses up our revenues and expenses, cashflow wise it should be net zero impact (that is if we have no profit margin applied to the supply of product for the BARDA trials). The lucrative aspect is the expected BARDA order(s) to fill their warehouse. Can anyone remember the shelf-life period, was it 2 years?
Some exciting posts here guys, thanks.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.030(2.49%) |
Mkt cap ! $811.7M | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.17 | $2.698M | 2.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4273 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 10804 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |